Product Description

🔹 Product Overview
Bdron 250 mg Tablet is a prescription anti-cancer medicine used in the treatment of advanced prostate cancer in adult men.
Contains Abiraterone Acetate 250 mg, an androgen biosynthesis inhibitor that helps reduce testosterone production, which can promote prostate cancer growth.
It is commonly prescribed along with prednisolone or prednisone as part of prostate cancer treatment.

🔹 Key Uses
Treatment of metastatic castration-resistant prostate cancer (mCRPC)
Treatment of metastatic castration-sensitive prostate cancer (mCSPC)
Helps slow the growth and spread of prostate cancer cells
Used as part of long-term hormonal cancer therapy.

🔹 Composition
Active ingredient: Abiraterone Acetate 250 mg
Therapeutic class: Anti-neoplastic / Anticancer Medicine
Available as oral tablets.

🔹 How It Works
Blocks the CYP17 enzyme, which is involved in androgen (male hormone) production.
Reduces testosterone levels that fuel prostate cancer growth.
Helps control disease progression and improve treatment outcomes.

🔹 Key Benefits
Effective prostate cancer treatment
Helps reduce androgen production
Supports long-term cancer management
Oral tablet formulation for convenient administration
Widely prescribed in advanced prostate cancer therapy.

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist.
Usually taken on an empty stomach (at least 1 hour before or 2 hours after food).
Swallow whole with water; do not crush or chew.
Often used together with prednisolone or prednisone.

🔹 Possible Side Effects
Fatigue
High blood pressure
Joint or muscle pain
Swelling in legs or feet
Diarrhea
Low potassium levels
Liver function abnormalities.

🔹 Precautions
Use only under specialist medical supervision.
Regular monitoring of liver function, blood pressure, and potassium levels is recommended.
Inform your doctor about heart, liver, or kidney conditions.
Avoid self-medication and follow prescribed treatment schedules.